Brief: Dicot's Rights Issue Heavily Oversubscribed

Dicot Pharma AB

24/06/2020 07:36

June 24 (Reuters) - Dicot AB  DICOT.TE :
    * DICOT'S RIGHTS ISSUE IS HEAVILY OVERSUBSCRIBED
    * THROUGH RIGHTS ISSUE, COMPANY OBTAINS APPROXIMATELY SEK
21.8
MILLION BEFORE ISSUE COSTS.
    * RIGHTS ISSUE WAS SUBSCRIBED TO 326 PERCENT.
    * ISSUE COSTS ARE ESTIMATED TO AMOUNT TO SEK 4.7 MILLION AND
CONSIST MAINLY OF COSTS FOR UNDERWRITING COMMITMENTS AND
COMPENSATION TO FINANCIAL AND LEGAL ADVISERS IN CONNECTION WITH
RIGHTS ISSUE.
    * UPON FULL EXERCISE OF ALL WARRANTS OF SERIES 2021 WITHIN
FRAMEWORK OF ISSUED UNITS, COMPANY MAY RECEIVE UP TO AN
ADDITIONAL SEK 43.6 MILLION, DEPENDING ON EXERCISE PRICE

Source text for Eikon:  ID:nWkr6FC78l 
Further company coverage:  DICOT.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))